WHO -GMP certificate for Cephalosporin facility
August 24, 2009
PDL gets listed on NSE and BSE
July 1, 2010
WHO -GMP certificate for Cephalosporin facility
August 24, 2009
PDL gets listed on NSE and BSE
July 1, 2010

Barwala Research and Development centre inaugurated

 

Barwala Research and Development Centre inaugurated

The Company’s dedicated, state of the art Research & Development Centre was inaugurated today on January 27, 2010 by honorable Mr. J. D. Gupta, retired IAS officer, Haryana Cadre at a gala function attended by dignitaries from state, financial institutions and Parabolic team.

Parabolic has taken the leap from a generic API manufacturer to being a strategic partner for Multi national companies across the world. Keeping in line with its long term vision of establishing itself in niche segments, the Company has set up a R&D centre at HSIIDC, Barwala. This centre, built over 4,200 sq. m., consists of 6 laboratories with 12 fume hoods each and separate laboratories equipped with the latest technical equipments for research work, including HPLC, Gas Chromatograph, X-Ray Diffraction system and Nuclear Magnetic Resonance, amongst others.

The company has a European GMP certified Cephalosporin manufacturing site at Derabassi, with an annual production capacity over 700 tonnes. Cefixime, an oral third generation Cephalosporin Antibiotic, has a world market size of USD 839 million (September 2010, IMS) growing at 20.9% annually. The molecule is growing across the world for its basic use in the treatment of gonorrhea, tonsilitis and pharyngitis. The European market contributes to over 18% in the total sales for this molecule.

There is a dedicated HPLC laboratory with 20 High Performance Liquid Chromatographs controlled with a Raid-5 server, a wet lab and one laboratory for other chemical tests. There is also a dedicated Kilo Lab, built as per cGMP guidelines, for scale up of new processes developed by the R&D wing of the Company. There is an in house documentation centre and IPR and Regulatory Affairs set up. This facility is designed to house over 100 scientists and would have facilities like online library, auditorium for meetings / seminars and trainings with complete set up for web conferences, recreation room and cafeteria. All the laboratories are designed to facilitate all types of testing within this facility and the site is intended to be completely cGMP & cGLP compliant.

The technology platforms on which Parabolic R&D functions are broadly based on focused technologies and our chemistry capabilities include Chiral chemistry, Heterocyclic chemistry, Hydrogenation, etc., amongst others. Since the mission and goal of differentiating Parabolic as a Research oriented Pharma company and a partner of choice for Contract Manufacturing for innovator companies across the globe is clear, the set up of this site would be a step towards the achievement of this mission.

Leave a Reply

Your email address will not be published. Required fields are marked *

fourteen + 11 =